These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7795286)

  • 41. [Severe exacerbation of chronic hepatitis B following interferon therapy].
    Laskus T; Radkowski M; Cianciara J; Loch T; Slusarczyk J
    Wiad Lek; 1992 Jun; 45(11-12):458-61. PubMed ID: 1441531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic viral hepatitis--benefits of current therapies.
    Hoofnagle JH; Lau D
    N Engl J Med; 1996 May; 334(22):1470-1. PubMed ID: 8618588
    [No Abstract]   [Full Text] [Related]  

  • 43. Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy in a patient with haemophilia A.
    Castenskiold EC; Colvin BT; Kelsey SM
    Br J Haematol; 1994 Jun; 87(2):434-6. PubMed ID: 7947296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy.
    Mels GC; Roffi L; Antonelli G; Bellati G; Pacchetti S; Di Nolfo MA; Panizzuti F; Moretti G; Piperno A; Pozzi M
    Prog Clin Biol Res; 1993; 382():359-64. PubMed ID: 8502704
    [No Abstract]   [Full Text] [Related]  

  • 46. Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: a retrospective study.
    Huang ML; Xu XT; Shen J; Qiao YQ; Dai ZH; Ran ZH
    J Crohns Colitis; 2014 Apr; 8(4):282-7. PubMed ID: 24067604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
    Robson SC; Brice E; van Rensburg C; Kannemeyer J; Hift RJ; Kirsch RE
    S Afr Med J; 1992 Nov; 82(5):317-20. PubMed ID: 1448711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Historical treatment of chronic hepatitis B and chronic hepatitis C.
    Ferenci P
    Gut; 1993; 34(2 Suppl):S69-73. PubMed ID: 8314494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
    Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. alpha-Interferon therapy for hepatitis C virus chronic infection with mixed cryoglobulinemia.
    Castilla A; Castilla I; Prieto J
    Am J Gastroenterol; 1993 Mar; 88(3):466-7. PubMed ID: 8438868
    [No Abstract]   [Full Text] [Related]  

  • 52. Recombinant alpha 2B interferon (IFN) in the treatment of chronic hepatitis C disease in thalassaemia major (TM).
    Wonke B; Donohue SM; Hoffbrand AV; Scheuer PJ; Brown D; Dusheiko G
    Bone Marrow Transplant; 1993; 12 Suppl 1():24-5. PubMed ID: 8397033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [How many patients with chronic viral hepatitis qualify for interferon therapy? Prospective analysis of university ambulatory care].
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Med Klin (Munich); 1993 Sep; 88(9):511-5, 562. PubMed ID: 8232088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of chronic hepatitis C virus infection with interferon in patients infected with the human immunodeficiency virus].
    Sánchez JF; Pascua J; Sánchez F; Crespo L; Briones A; Martín C
    An Med Interna; 1994 Dec; 11(12):575-9. PubMed ID: 7734662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transient hypothyroidism in a child treated with alpha-interferon for chronic hepatitis B infection.
    Abdul-Jabbar MA; Ehrlich RM; Mann N; Roberts EA
    Clin Pediatr (Phila); 1995 Dec; 34(12):663-5. PubMed ID: 8665748
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of chronic hepatitis B and C with alpha interferon].
    Hess G
    Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130
    [No Abstract]   [Full Text] [Related]  

  • 57. Chronic hepatitis C and markedly elevated serum alpha-fetoprotein: complete response to treatment with alpha-interferon.
    Weinberg DS; Malet PF
    Am J Gastroenterol; 1994 Aug; 89(8):1253-4. PubMed ID: 7519819
    [No Abstract]   [Full Text] [Related]  

  • 58. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Attempted suicide during treatment of chronic viral hepatitis C with interferon. Apropos of 2 cases].
    Bourat L; Larrey D; Michel H
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1063. PubMed ID: 8729421
    [No Abstract]   [Full Text] [Related]  

  • 60. Interferon-alpha treatment of haemodialysis patients with chronic viral hepatitis and its impact on kidney transplantation.
    Simsek H
    Nephrol Dial Transplant; 1996 May; 11(5):912-3. PubMed ID: 8671933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.